GM-CSF administration to hypercholesterolaemic mice was shown to accelerate AAA formation (71), while GM-CSF inhibition dampened AAA development in mice which was associated with decreased inflammation and related MMP expression/activity, and elevated GM-CSF expressing inflammatory cells were detected within human AAA samples compared to non-diseased aortic samples (72). The gene discussed is CSF2; the disease is triple-A syndrome.